The American Diabetes Association® (ADA) applauds bipartisan members of the U.S. House of Representatives Diana DeGette (CO-01), Mariannette Miller-Meeks (IA-01), Kim Schrier (WA-08), Rob Bresnahan Jr. (PA-08), and Angie Craig (MN-02) for introducing the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026. Building on the strong bipartisan leadership and momentum in the Senate, the House of Representatives is tackling the ongoing insulin affordability crisis facing millions of individuals.
For the more than 40 million Americans living with diabetes, many of whom rely on insulin every day to survive, this legislation represents a critical step forward in ensuring that lifesaving medication is both accessible and affordable. The ADA commends lawmakers for this essential step that allows the bill to be considered by the House of Representatives.
Polling released by the ADA found that among respondents who rely on insulin, 72% reported paying more than $35 per month, and nearly 40% pay more than $150 monthly for the lifesaving medication. That high price forces some to ration, skip, or delay doses.
The INSULIN Act of 2026 would lower out-of-pocket insulin costs to $35 per month and eliminate unnecessary barriers to care. Reducing patient costs allows many individuals to access the insulin they need, when they need it, without delay due to financial hardship. Bipartisan support and advancement in the House and Senate are essential to delivering real, lasting change for people living with diabetes.
The ADA also strongly supports the Senate’s proposed five-year pilot grant program to expand access to low-cost insulin for people who are uninsured. Including this critical provision would help ensure insulin affordability reaches those who often face the greatest barriers to accessing lifesaving medication.
The ADA urges swift action to advance the INSULIN Act of 2026 through both chambers of Congress so this bill can become law before the end of this year.
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. For 86 years, the ADA has driven discovery and research to treat, manage, and prevent diabetes while working relentlessly for a cure. Through advocacy, program development, and education we work to improve the quality of life for the over 155 million Americans living with diabetes or prediabetes. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
